Protocol Number; CAIN457L1401
Not Applicable
- Conditions
- psoriasis vulgaris,psoriatic arthritis,pustular psoriasis
- Registration Number
- JPRN-jRCT2031210589
- Lead Sponsor
- Toshiya Sugimoto
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
1.Patients who have obtained written consent from their legally acceptable representative to cooperate in this survey before the start of treatment with this drug
2.Patients aged less than 18 years at the start of treatment with this drug
3.Patients newly treated with this drug for any of the following diseases: Psoriasis vulgaris, psoriatic arthritis, pustular psoriasis
Exclusion Criteria
1.Prior treatment with this drug
2.Participation in an interventional study (e.g., a clinical trial) at the time of starting this drug.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method